Cronos Group Inc (TSE:CRON) CEO on Ginkgo Bioworks Partnership to Produce Cultured CBDs

Cronos Group Inc (NASDAQ:CRON) (TSE:CRON) (FRA:7CI) CEO Mike Gorenstein explains the company’s recent deal with Ginkgo Bioworks, the market leader in terms of DNA printing, to produce cultured CBDs. Gorenstein envisions culture CBDs as the direction the cannabis industry is going, instead of CBDs produced from plants. Cronos has also announced operations in Latin America through an affiliate, Agroidea SAS, Colombia’s leading agricultural services provider. Gorenstein believes Agroidea SAS is the perfect fit to be Cronos’ flower-based global exporter because of climate, labour costs, and expertise. Gorenstein shares his thoughts on the increase in institutional investors in the cannabis space and what this means for Cronos going forward.

************************

Check out our website:
https://midasletter.com

************************

SUBSCRIBE to our YouTube:
http://bit.ly/MidasLetterYoutube

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter:
http://bit.ly/MidasLetterTwitter

Like Us on Instagram:
http://bit.ly/MidasLetterInsta

Like Us on Facebook:
http://bit.ly/MidasLetterFacebook

************************

#Cronos
#WeedStocks
#CBD

Тэги:

#economy #news #cannabis #investing #companies #weed_stocks #pot_stocks #cronos #tse:cron #ginkgo #cbd #lab #research #citron #short

Скачать видео